Batterjee Pharmaceutical

What Batterjee Pharmaceutical does

Batterjee Pharmaceutical Factory is a privately held, family-owned pharmaceutical manufacturer headquartered in Jeddah, Saudi Arabia, with operations rooted in the Batterjee family's healthcare legacy dating to the late 1940s. The company manufactures a broad portfolio of generic pharmaceutical products across multiple dosage forms including tablets, capsules, syrups, suspensions, emulsions, ointments, creams, gels, mouthwash, and antiseptic products, and is expanding into soft gelatin capsules, powder, and sachets. Its therapeutic coverage spans cardiovascular (AMLOCARD, UNIPROST), anti-infective (LEVOBAT, SECNID, SOFOCURE), dermatological (ECZADERM, MYCOLESS, FUNGO), gastrointestinal (PANTOLOC, ACICAL), antihistamine/allergy (FEXOTEL, RIZINO), respiratory, and supplement categories (EVIT, MAXICAL, ROYAL 1000). Manufacturing is conducted in a cGMP-certified facility in Jeddah Industrial City, licensed by the Saudi Food and Drug Authority and registered with the Ministry of Health and GCC Drug Registration Authority.

The company operates three revenue streams: (1) proprietary generic pharmaceutical product sales to hospitals, pharmacies, and healthcare institutions in Saudi Arabia; (2) contract and toll manufacturing services for multinational pharmaceutical firms including Abbott, Takeda, Bristol Myers Squibb, Servier, Glenmark, and Acino; and (3) under-licensed branded product manufacturing for multinational companies. Pricing is quote-based and not publicly disclosed. Go-to-market combines a direct enterprise sales force targeting institutional tenders and healthcare providers with a regional distribution network of local agents in nine countries (UAE, Bahrain, KSA, Oman, Qatar, Kuwait, Iraq, Sudan, Yemen) responsible for product registration and market development. The company employs 251–500 staff, has no disclosed external investors or parent company, and operates as a self-funded family enterprise.

Name

Batterjee Pharmaceutical

Legal name

Batterjee Pharmaceutical Factory

Website

https://batterjeepharma.com

Company type

Private

Founded year

1940

Operating status

Operating

Headcount range

251–500 employees

Short description

Batterjee Pharmaceutical Factory is a family-owned Saudi Arabian manufacturer of generic and under-licensed pharmaceutical products headquartered in Jeddah. It also provides contract manufacturing services to multinational pharmaceutical firms and distributes across nine Middle Eastern and African markets.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

Keywords

• Generic pharmaceutical manufacturing
• Contract manufacturing services
• Pharmaceutical product distribution
• Generic drug formulations
• Pharmaceutical export services

Headquarters

HQ city

Jeddah

HQ country

Saudi Arabia

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Generic Pharmaceutical Product Sales: Manufacturing and marketing proprietary range of generic pharmaceutical products and supplements covering therapeutic areas including cardiovascular, anti-infective, dermatological, gastrointestinal, and respiratory products.
2. Contract Manufacturing Services: Toll manufacturing and contract manufacturing services for multinational and regional pharmaceutical companies requiring third-party manufacturing in Saudi Arabia and GCC markets. Services include full manufacturing or packaging for Saudi and GCC market.
3. Under-Licensed Branded Products: Developing relationships with multinational companies to under-license their branded products, generating revenue through licensed product manufacturing and distribution.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Batterjee Pharmaceutical Factory manufactures and markets a proprietary range of generic pharmaceutical products and supplements across therapeutic areas including cardiovascular, anti-infective, dermatological, gastrointestinal, and respiratory conditions, in dosage forms including tablets, capsules, syrups, suspensions, emulsions, ointments, creams, gels, mouthwash, and antiseptic products. The company also provides contract manufacturing and toll manufacturing services for multinational and regional pharmaceutical companies seeking third-party production for the Saudi and GCC markets.

Product overview

Batterjee Pharma is a Saudi Arabian pharmaceutical company headquartered in Jeddah that manufactures and markets a diverse portfolio of generic pharmaceutical products. The company operates its own range of generic products across multiple therapeutic categories including cardiovascular medications (AMLOCARD, UNIPROST), antibiotics (LEVOBAT, FUSIZONE), antivirals (SOFOCURE), gastrointestinal products (ACICAL, PANTOLOC), antihistamines (RIZINO, FEXOTEL), dermatological treatments (ECZADERM, MYCOLESS, FUNGO), supplements (MAXICAL, ROYAL 1000, EVIT 400), and topical analgesics (LEDO, UNITUM GEL). The product portfolio includes tablets, capsules, syrups, ointments, creams, gels, and mouthwashes. In addition to its own product line, Batterjee Pharma provides contract manufacturing services for multinational pharmaceutical companies including Abbott, Takeda, Bristol Myers Squibb, Servier, Glenmark, and Acino.

Differentiator

Problem solved

Functional benefit

Products and services

• EVIT 400 Vitamin E (dl-alpha-tocopheryl acetate) 400mg soft gelatin capsules with antioxidant properties that scavenge free radicals and protect biological membranes.
• SECNID
• UNIGENS
• ACICAL Plus
• ACICAL
• AMLOCARD
• UNIPROST
• ROYAL 1000
• GINKOGIN
• UNIZYM
• PANTOLOC
• RIZINO
• EVIT ANTIOXIDANT CREAM
• UNITUM BERDE
• MAXICAL
• FEXOTEL
• MYCOLESS
• CLOTRIZOLE
• LEDO
• UNITUM GEL
• FUNGO
• BETASAL
• FUSIZONE
• ECZADERM Ointment
• ECZADERM Cream
• SOFOCURE
• LEVOBAT
• Contract Manufacturing Services
• Under-Licensed Branded Products

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

15 partnerships are on record, tiered regional and major.

• Gulf Drug LLC (UAE)regionalChannel Partner/ Reseller/ DistributorRegional distribution partner in UAE responsible for registering Batterjee Pharma products and building brand presence. Located in Al Barsha, Dubai with contact details for product distribution.
• Cigalah Gulf Medical (Bahrain)regionalChannel Partner/ Reseller/ DistributorRegional distribution partner in Bahrain handling product registration and market development for Batterjee Pharma products in the Bahraini market.
• Cigalah Gulf (KSA)regionalChannel Partner/ Reseller/ DistributorRegional distribution partner operating in Saudi Arabia for Batterjee Pharma product registration and market building activities.
• Ibn Sina Pharmacy LLC (Oman)regionalChannel Partner/ Reseller/ DistributorRegional distribution partner in Oman responsible for product registration and distribution of Batterjee Pharma products in the Omani market.
• Wellcare Group (Qatar)regionalChannel Partner/ Reseller/ DistributorRegional distribution partner in Qatar handling Batterjee Pharma product registration and market development.
• H.S.Al-Homaizi Gransons Pharmaceutical Co. (Kuwait)regionalChannel Partner/ Reseller/ DistributorRegional distribution partner in Kuwait responsible for registering and distributing Batterjee Pharma products in the Kuwaiti market.
• Al Yusr (Iraq)regionalChannel Partner/ Reseller/ DistributorRegional distribution partner in Iraq handling product registration and market building for Batterjee Pharma products.
• Wafra for Infrastructure Co. (Sudan)regionalChannel Partner/ Reseller/ DistributorRegional distribution partner in Sudan responsible for registering and distributing Batterjee Pharma products in the Sudanese market.
• Al Rashad Co. (Yemen)regionalChannel Partner/ Reseller/ DistributorRegional distribution partner in Yemen handling product registration and market development for Batterjee Pharma products.
• AbbottmajorStrategic or Co-development PartnerContract manufacturing client for pharmaceutical products. Batterjee Pharma serves as third-party manufacturer for Abbott's branded pharmaceutical products in Saudi Arabia and GCC markets.
• TakedamajorStrategic or Co-development PartnerContract manufacturing client for pharmaceutical products. Batterjee Pharma provides manufacturing services for Takeda's products in the regional market.
• Bristol Myers SquibbmajorStrategic or Co-development PartnerContract manufacturing client for pharmaceutical products. Batterjee Pharma serves as third-party manufacturer for Bristol Myers Squibb's branded products.
• ServiermajorStrategic or Co-development PartnerContract manufacturing client for pharmaceutical products. Batterjee Pharma provides manufacturing services for Servier's products in the regional market.
• GlenmarkmajorStrategic or Co-development PartnerContract manufacturing client for pharmaceutical products. Batterjee Pharma serves as manufacturing partner for Glenmark's products.
• AcinomajorStrategic or Co-development PartnerContract manufacturing client for pharmaceutical products. Batterjee Pharma provides third-party manufacturing services for Acino's branded products.

Scale indicators2 records

Recent moves2 records

Expansion highlights5 records

Direct peers

• Julphar (Gulf Pharmaceutical Industries): UAE-headquartered generic and specialty pharmaceutical manufacturer with regional distribution across the Middle East and Africa. Comparable in scale, dosage-form breadth (tablets, capsules, syrups, injectables) and SFDA/GCC regulatory posture.
• Neopharma: UAE-based pharmaceutical manufacturer with multi-therapeutic generic portfolio and a strategic focus on contract manufacturing for multinational partners. Highly comparable to Batterjee's CMO business model and regional GCC positioning.
• Avalon Pharma: Saudi-based pharmaceutical manufacturer focused on dermatology, personal care and OTC products. Closest Saudi peer in the dermatology and topical-preparation segments where Batterjee fields multiple SKUs (ECZADERM, MYCOLESS, FUNGO, BETASAL).
• Tabuk Pharmaceuticals: Saudi-based pharmaceutical manufacturer producing generics and branded products with multi-country GCC distribution and a contract manufacturing arm — structurally very similar to Batterjee across product portfolio, regulatory scope and export footprint.
• SPIMACO Addwaeih: Saudi Arabia's largest publicly-listed generic pharmaceutical manufacturer, headquartered in Qassim with a comparable SFDA-licensed, cGMP-certified plant portfolio and similar generic product mix across cardiovascular, anti-infective, dermatology and respiratory categories. Most direct Saudi comparator by business model and therapeutic coverage.
• Saudi Drug Store Company: Long-established Saudi pharmaceutical manufacturer and distributor with a heritage comparable to Batterjee's. Operates similar generic lines and benefits from the same Vision 2030 localization tailwinds.

Broad incumbents

• Hikma Pharmaceuticals: Jordan-headquartered multinational pharmaceutical company with significant MENA manufacturing and commercial operations. Overlaps with Batterjee on generic injectables, oral solids and contract manufacturing, but operates at materially larger global scale with sterile and biologic capabilities.
• Aurobindo Pharma: Indian-headquartered global generic manufacturer with strong presence in the Middle East and Africa. Competes with Batterjee in generic cardiovascular, anti-infective and GI categories across GCC tenders at significantly larger scale.
• Cipla: Indian-headquartered global generic manufacturer with active distribution in the GCC and Africa. Competes with Batterjee in respiratory, cardiovascular and anti-infective categories across MENA markets but at materially greater scale and product breadth.

Regional players

• EIPICO (Egyptian International Pharmaceutical Industries Company): Egypt's largest generic pharmaceutical manufacturer with broad therapeutic coverage and dosage-form breadth. Comparable product portfolio and contract manufacturing ambitions, but primarily serves the Egyptian and African markets rather than GCC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/batterjepharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Batterjee Pharmaceutical